Sickle cell disease causes premature aging of blood stem cells, which scientists may be able to address with a special class of drugs, according to a new study from St. Jude Children's Research ...

July 21 (Reuters) - Agios Pharmaceuticals said on Tuesday it is discontinuing development of its sickle cell disease treatment after trial results failed to show enough benefit to support further ...

Gene editing has delivered remarkable results against sickle cell disease. Now researchers are working to make these personalized treatments faster, cheaper, and available to far more patients.

Right now, approximately 20 billion red blood cells are busy traveling through your blood vessels. They are delivering oxygen to all the different tissues in your body and removing carbon dioxide to ...

Hemoglobin response rates for tebapivat, a PK activator, were consistent with the class of medicine, but Phase 2 results did not establish a ...

The study failure costs Agios a chance to one-up Novo Nordisk and represents yet another setback in a disease that’s ...

The father of a teenager from Guinea with sickle cell disease who died days after he was arrested for cheating in an exam has ...

Agios Pharmaceuticals shares rose Tuesday after the U.S. Food and Drug Administration granted priority review to the company's supplemental new drug application for mitapivat to treat sickle cell ...

Sickle cell disease (SCD) can affect people of any ethnicity but is much more common among Africans and African Americans. Other ethnic groups with higher rates of SCD include Hispanic Americans from ...

Sickle cell disease remains a major public health challenge in India, particularly among tribal populations. According to ...

Having a part of his spleen removed and a rare chronic disease hasn’t stopped 12-year-old E’Shon Guy from living a normal ...

Family members have called for an independent investigation into CaSandra Pearson's death, saying she belonged in a hospital ...